Discontinuation report ABILIFY
Report ID | 129986 |
Drug Identification Number | 02322382 |
Brand name | ABILIFY |
Common or Proper name | ARIPIPRAZOLE |
Company Name | OTSUKA PHARMACEUTICAL CO LTD |
Market Status | MARKETED |
Active Ingredient(s) | ARIPIPRAZOLE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | BLISTER format only |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-04-30 |
Actual discontinuation date | 2021-04-30 |
Remaining supply date | 2021-04-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Samples in blister format are available until the discontinuation date. |
Company comments | ONLY BLISTER (sample) format is discontinued. The bottle format is still available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2-9 KANDA-TSUKASAMACHI CHIYODA-KU TOKYO, -- JAPAN 101-8535 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2021-05-01 | English | Compare |
v2 | 2020-12-10 | French | Compare |
v1 | 2020-12-10 | English | Compare |
Showing 1 to 3 of 3